These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1799664)

  • 21. Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients.
    Castillo R; Monteagudo J; Escolar G; Ordinas A; Magallón M; Martín Villar J
    Blood; 1991 May; 77(9):1901-5. PubMed ID: 1902120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of circulating immune complexes on transfusional therapy in patients with hemophilia or von Willebrand's disease.
    Celada A; Aguado MT; Maire M; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Transfusion; 1984; 24(1):46-52. PubMed ID: 6420954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryoprecipitate transfusion in variant von Willebrand's disease and thrombocytopenia.
    Krizek DM; Rick ME; Williams SB; Gralnick HR
    Ann Intern Med; 1983 Apr; 98(4):484-6. PubMed ID: 6404206
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of von Willebrand's disease.
    Aledort LM
    Mayo Clin Proc; 1991 Aug; 66(8):841-6. PubMed ID: 1907343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Von Willebrand's disease].
    Furlan M
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1798-806. PubMed ID: 3122318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of cryoprecipitate in the treatment of von Willebrand's disease].
    Dyszy-Laube B; Zywicka-Lopaciuk H; Lopaciuk S
    Pediatr Pol; 1970 Aug; 45(8):911-5. PubMed ID: 5311867
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic effect of heat-treated factor VIII concentrates in von Willebrand's disease and related disorders: studies in platelet-type von Willebrand's disease].
    Takahashi H; Tatewaki W; Nagayama R; Hanano M; Takizawa S; Tamura M; Yamaguchi T; Wada K; Shibata A
    Rinsho Ketsueki; 1987 Dec; 28(12):2117-24. PubMed ID: 3133507
    [No Abstract]   [Full Text] [Related]  

  • 31. New approach of the treatment of von Willebrand's disease during pregnancy.
    Gojnic M; Fazlagic A; Likic I; Stefanovic A; Vidakovic S; Pervulov M; Petkovic S; Mostic T; Miljic P; Bogdanovic A
    Arch Gynecol Obstet; 2005 Nov; 273(1):35-8. PubMed ID: 16172853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of intensive plasma exchange in acquired von Willebrand's disease.
    Silberstein LE; Abrahm J; Shattil SJ
    Transfusion; 1987; 27(3):234-7. PubMed ID: 3109084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major surgery in von Willebrand's disease.
    Dokal I; Bradshaw A; Stoneham A; Bowcock S; Coombs R; Royston D; Taylor K; Hows J
    Clin Lab Haematol; 1989; 11(3):205-11. PubMed ID: 2512045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type IIB von Willebrand's disease: unusual response to cryoprecipitate infusion.
    Weinger RS; Cimo PL; Moake JL; Olson JD; Heller MS
    Ann Intern Med; 1981 Jan; 94(1):47-50. PubMed ID: 6778284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet aggregation induced by cryoprecipitate infusion in platelet-type von Willebrand's disease.
    Takahashi H; Okada K; Abe S; Wada K; Nagayama R; Tatewaki W; Hanano M; Takizawa S; Shibata A
    Thromb Res; 1987 Apr; 46(2):255-62. PubMed ID: 3496681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aortic valve replacement in von Willebrand's disease.
    Young PH; Bouhasin JD; Barner HB
    J Thorac Cardiovasc Surg; 1978 Aug; 76(2):218-22. PubMed ID: 308120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Haemate-P as prophylaxis of recurrent bleeding in a patient with type 2B von Willebrand's disease.
    Franchini M; Giuffrida A; Gandini G
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):571-2. PubMed ID: 16269931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.